SFRP4 and benign neoplasm: Analysis revealed that the majority of benign and borderline tumours exhibited sFRP4 expression, while adenocarcinomas demonstrated a significantly reduced sFRP4 expression compared to borderline and benign tumours (p < 0.001) (Figure 9).